| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |